Table 4.
n=92 (%) | RA + SLE (n=92)
|
RA (n=55)
|
SLE (n=37)
|
||||
---|---|---|---|---|---|---|---|
Prevalence, n (%) | P-value | Prevalence, n (%) | P-value | Prevalence, n (%) | P-value | ||
Patient is aware of the reason of treatment | 1.000a | 0.677a | 1.000a | ||||
Yes | 84 (91.30) | 24 (28.57) | 8 (16.33) | 16 (45.71) | |||
No | 8 (8.69) | 2 (25.00) | 1 (25.00) | 1 (50.00) | |||
Patient is aware of adverse effects | 0.728 | 1.000a | 0.769 | ||||
Yes | 54 (58.69) | 16 (29.63) | 5 (16.13) | 11 (47.83) | |||
No | 38 (41.30) | 10 (26.32) | 4 (16.66) | 6 (42.86) | |||
Patient is aware of drug interactions | 0.269 | 0.680a | 0.492 | ||||
Yes | 18 (20.45) | 7 (38.89) | 2 (22.22) | 5 (55.56) | |||
No | 70 (79.55) | 18 (25.71) | 7 (15.90) | 11 (42.31) | |||
Patient search for more information about medications | 0.426 | 0.467a | 0.942 | ||||
Yes | 46 (50.00) | 11 (24.44) | 4 (12.50) | 7 (46.67) | |||
No | 46 (50.00) | 15 (31.91) | 5 (21.74) | 10 (45.45) |
Note:
Fisher’s exact test.
Abbreviations: RA, rheumatoid arthritis; SLE, systemic lupus erythematosus.